Halo Pharma serves a growing global customer base across multiple regulatory environments. These attributes allow Halo Pharma to be a partner of choice for many of today’s large pharma, generic pharma and biotech pharma companies.
Halo Pharma offers fully integrated capabilities and turn-key commercial manufacturing services in a variety of dosage forms and drug delivery platforms including complex formulations, such as modified release tablets, capsules, topicals (sterile and non-sterile), and oral solutions.
Halo Pharma has the ability to manufacture phase I-III clinical supplies in a variety of dosage forms.
Halo Pharma is a premier contract development and manufacturing organization (CDMO) that provides scientific, product development, commercial and clinical manufacturing services from its multiple locations in North America.
The company is US FDA, EU and Health Canada approved and licensed to handle drug products and raw materials with DEA CI-CV DEA designations. Halo Pharma's expertise in the areas of technical transfer, process and product development, manufacturing, packaging, scale-up/validation as well as capabilities that span the full range of analytical testing services including method development, validation and stability services, allows Halo to partner with our customers from development through to commercialization.
In pediatric dosage formulation, size matters. Halo Pharma's Pediatric Center of Excellence is uniquely equipped to support the development and manufacture of dosage forms tailored for pediatric and other small patient populations.
Complex fixed-dose combination products from Halo may improve patient compliance, reduce dosing complexity, and provide a differentiated approach to marketing your product.
Our Whippany, New Jersey location houses our Corporate Headquarters. The facility provides cGMP compliant manufacturing and packaging services. The facility has been manufacturing drug products for over 40 years and has an excellent FDA, MHRA and DEA compliance record. Continuously updated over the years, with state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulation technologies.
Whippany is perfectly suited to handle either high-volume or small batch manufacturing, for a wide range of solid, liquid and ointment (sterile and non-sterile) dosage forms. The facility includes laboratories for analytical method development and validation, method transfers, QC release and stability testing as well as microbiology testing. A variety of packaging services are also available.
Read more
Montreal Operations is a highly compliant cGMP facility for pharmaceutical manufacturing and packaging located just outside Montreal in Canada. The facility has been manufacturing drug products for over 40 years and has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant utilizes cutting-edge laboratory and manufacturing technologies.
The Montreal facility is perfectly suited to handle either high-volume (hundreds of kilograms) or small batch (2-3 kg) manufacturing, for a wide range of solid dose, liquids – including suspensions and solutions, and nonsterile semisolids – including lotions, creams and ointments and suppositories. The facility includes laboratories for analytical method development and validation, method transfers, release and microbiology testing on both raw materials and finished goods. A variety of packaging services are also available in bottles, tubes and cartons.
Read moreMany Pharmaceutical companies are continuing to rely on third-party providers for support at all levels of drug development. As a CDMO Halo offers advanced, specialized technologies in combination with tailored support to meet the client’s changing requirements throughout the product lifecycle.
